Validated Postbiotic Screening Confirms Presence of Physiologically-Active Metabolites, Such as Short-Chain Fatty Acids, Amino Acids and Vitamins in Hylak® Forte

Probiotics and Antimicrobial Proteins

Volumn 11, Issue 4, 2019, Pages 1124-1131

  Patil, Satish ^a   Sawant, Sarvesh ^a   Hauff, Karlheinz ^b   Hampp, Gabriele ^b  

^a Teva Pharmaceutical Industries   (India)

^b ratiopharm GmbH   (Germany)

Author keywords

Gastrointestinal tract; Hylak forte; Metabiotics; Postbiotics; SCFA; Vitamins

Indexed keywords

ACETIC ACID; ALANINE; AMINO ACID; CALCIUM; DISACCHARIDE; FORMIC ACID; GLUTAMIC ACID; GLUTAMINE; GLYCINE; HISTIDINE; HYLAK; ISOLEUCINE; LEUCINE; LYSINE; MAGNESIUM; MONOSACCHARIDE; PANTOTHENIC ACID; PROBIOTIC AGENT; PROLINE; PYRIDOXINE; RIBOFLAVIN; SHORT CHAIN FATTY ACID; THIAMINE; THREONINE; VALINE; VITAMIN; ORGANIC COMPOUND; VOLATILE FATTY ACID;

ARTICLE; BACTERIUM CULTURE; CHEMICAL ANALYSIS; CONTROLLED STUDY; DEGRADATION; DRUG STABILITY; ENTEROCOCCUS FAECALIS; ESCHERICHIA COLI; GAS CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LACTOBACILLUS ACIDOPHILUS; LACTOBACILLUS HELVETICUS; LIMIT OF DETECTION; LIMIT OF QUANTITATION; LINEARITY; MEASUREMENT ACCURACY; MEASUREMENT PRECISION; METABOLITE; NONHUMAN; PRIORITY JOURNAL; PURIFICATION; ROBUSTNESS; SCREENING; CHEMISTRY; METABOLISM;

AMINO ACIDS; CHROMATOGRAPHY, GAS; FATTY ACIDS, VOLATILE; ORGANIC CHEMICALS; PROBIOTICS; VITAMINS;

EID: 85058792829     PISSN: 18671306     EISSN: 18671314     Source Type: Journal    
DOI: 10.1007/s12602-018-9497-5     Document Type: Article

References (44)

1. Kamada N, Chen GY, Inohara N, Núñez G (2013) Control of pathogens and pathobionts by the gut microbiota. Nat Immunol 14:685–690. 10.1038/ni.2608
2. Neis EPJG, Dejong CHC, Rensen SS (2015) The role of microbial amino acid metabolism in host metabolism. Nutrients 7:2930–2946. 10.3390/nu7042930
3. Thursby E, Juge N (2017) Introduction to the human gut microbiota. Biochem J 474:1823–1836. 10.1042/BCJ20160510
4. Conlon MA, Bird AR (2014) The impact of diet and lifestyle on gut microbiota and human health. Nutrients 7:17–44. 10.3390/nu7010017
5. Ulluwishewa D, Anderson RC, McNabb WC, Moughan PJ, Wells JM, Roy NC (2011) Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr 141:769–776. 10.3945/jn.110.135657
6. Trompette A, Gollwitzer ES, Yadava K, Sichelstiel AK, Sprenger N, Ngom-Bru C, Blanchard C, Junt T, Nicod LP, Harris NL, Marsland BJ (2014) Gut microbiota metabolism of dietary fiber influences allergic airway disease and hematopoiesis. Nat Med 20:159–166. 10.1038/nm.3444
7. Vieira AT, Fukumori C, Ferreira CM (2016) New insights into therapeutic strategies for gut microbiota modulation in inflammatory diseases. Clin Transl Immunol 5:e87. 10.1038/cti.2016.38
8. Adams CA (2010) The probiotic paradox: live and dead cells are biological response modifiers. Nutr Res Rev 23:37–46. 10.1017/S0954422410000090
9. Bermudez-Brito M, Plaza-Díaz J, Muñoz-Quezada S, Gómez-Llorente C, Gil A (2012) Probiotic mechanisms of action. Ann Nutr Metab 61:160–174. 10.1159/000342079
10. Madsen K, Cornish A, Soper P, McKaigney C, Jijon H, Yachimec C, Doyle J, Jewell L, De Simone C (2001) Probiotic bacteria enhance murine and human intestinal epithelial barrier function. Gastroenterology 121:580–591. 10.1053/gast.2001.27224
11. Tsilingiri K, Rescigno M (2013) Postbiotics: what else? Benefic Microbes 4:101–107. 10.3920/BM2012.0046
12. Hylak® forte User Information. https://www.google.de/search?q=hylak+user+forte+user+infomration&rlz=1C1EJFA_enDE781DE781&oq=hylak+user+forte+user+infomration&aqs=chrome.69i57j33.7326j1j4&sourceid=chrome&ie=UTF-8. Accessed 20 Aug 2002, last revision March 2016
13. Ríos-Covián D, Ruas-Madiedo P, Margolles A, Gueimonde M, de los Reyes-Gavilán CG, Salazar N (2016) Intestinal short chain fatty acids and their link with diet and human health. Front Microbiol 7:185. 10.3389/fmicb.2016.00185
14. Macfarlane GT, Macfarlane S (2012) Bacteria, colonic fermentation, and gastrointestinal health. J AOAC Int 95:50–60. 10.5740/jaoacint.SGE_Macfarlane
15. ICH harmonised tripartite guideline. Validation of analytical procedures: text and methodology Q2(R1). https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guideline.pdf. Accessed 2016
16. Metcalfe LD, Schmitz AA (1961) The rapid preparation of fatty acid esters for gas chromatographic analysis. Anal Chem 33:363–364. 10.1021/ac60171a016
17. Shenderov BA (2013) Metabiotics: novel idea or natural development of probiotic conception. Microb Ecol Health Dis 24:20399. 10.3402/mehd.v24i0.20399
18. Belousova EF, Nikitine YV, Mishurovskaya NC, Zlatkina AR (2005) Possibilities of microbial metabolite preparations for intestinal microbiota restoration. Cons Medicum 7:9–13
19. Hiller E, Schach H (1955) Clinical and experimental experiences on the possibility of the influence of yoghurt metabolites on pathological conditions of intestinal flora. Arzneimittelforschung 5:592–599
20. Konig H, Manz W, Singer U (1991) Influence on intestinal bacteria. Basic principles of treatment using bacterial metabolic products. Der Kassenarzt 18:52–61
21. Krieger D, Vanek E, Manz W, Elsasser R (1991) Influence of bacterial metabolic products on the fecal flora of healthy volunteers and on added pathogenic bacteria. Nb Med 4:169–172
22. den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM (2013) The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 54:2325–2340. 10.1194/jlr.R036012
23. Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, Tobe T, Clarke JM, Topping DL, Suzuki T, Taylor TD, Itoh K, Kikuchi J, Morita H, Hattori M, Ohno H (2011) Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature 469:543–547. 10.1038/nature09646
24. Cummings JH (1981) Short chain fatty acids in the human colon. Gut 22:763–779. 10.1136/gut.22.9.763
25. Topping DL, Clifton PM (2001) Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 81:1031–1064. 10.1152/physrev.2001.81.3.1031
26. Morrison DJ, Preston T (2016) Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes 7:189–200. 10.1080/19490976.2015.1134082
27. Miller TL, Wolin MJ (1996) Pathways of acetate, propionate, and butyrate formation by the human fecal microbial flora. Appl Environ Microbiol 62:1589–1592
28. Flint HJ, Duncan SH, Scott KP, Louis P (2015) Links between diet, gut microbiota composition and gut metabolism. Proc Nutr Soc 74:13–22. 10.1017/S0029665114001463
29. Macfarlane S, Macfarlane GT (2003) Regulation of short-chain fatty acid production. Proc Nutr Soc 62:67–72. 10.1079/PNS2002207
30. Louis P, Hold GL, Flint HJ (2014) The gut microbiota, bacterial metabolites and colorectal cancer. Nat Rev Microbiol 12:661–672. 10.1038/nrmicro3344
31. Pomare EW, Branch WJ, Cummings JH (1985) Carbohydrate fermentation in the human colon and its relation to acetate concentrations in venous blood. J Clin Invest 75:1448–1454. 10.1172/JCI111847
32. Pessione E (2012) Lactic acid bacteria contribution to gut microbiota complexity: lights and shadows. Front Cell Infect Microbiol 2:86. 10.3389/fcimb.2012.00086
33. Elshaghabee FMF, Bockelmann W, Meske D, de Vrese M, Walte HG, Schrezenmeir J, Heller KJ (2016) Ethanol production by selected intestinal microorganisms and lactic acid bacteria growing under different nutritional conditions. Front Microbiol 7:47. 10.3389/fmicb.2016.00047
34. Enjalbert B, Millard P, Dinclaux M, Portais JC, Létisse F (2017) Acetate fluxes in Escherichia coli are determined by the thermodynamic control of the Pta-AckA pathway. Sci Rep 7:42135. 10.1038/srep42135
35. Torino MI, Mozzi F, Font de Valdez G (2005) Exopolysaccharide biosynthesis by Lactobacillus helveticus ATCC 15807. Appl Microbiol Biotechnol 68:259–265. 10.1007/s00253-004-1865-2
36. Tedelind S, Westberg F, Kjerrulf M, Vidal A (2007) Anti-inflammatory properties of the short-chain fatty acids acetate and propionate: a study with relevance to inflammatory bowel disease. World J Gastroenterol 13:2826–2832. 10.3748/wjg.v13.i20.2826
37. Brown AJ, Goldsworthy SM, Barnes AA, Eilert MM, Tcheang L, Daniels D, Muir AI, Wigglesworth MJ, Kinghorn I, Fraser NJ, Pike NB, Strum JC, Steplewski KM, Murdock PR, Holder JC, Marshall FH, Szekeres PG, Wilson S, Ignar DM, Foord SM, Wise A, Dowell SJ (2003) The orphan G protein-coupled receptors GPR41 and GPR43 are activated by propionate and other short chain carboxylic acids. J Biol Chem 278:11312–11319. 10.1074/jbc.M211609200
38. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, di Yu, Schilter HC, Rolph MS, Mackay F, Artis D, Xavier RJ, Teixeira MM, Mackay CR (2009) Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 461:1282–1286. 10.1038/nature08530
39. Hill MJ (1997) Intestinal flora and endogenous vitamin synthesis. Eur J Cancer Prev 6(Suppl 1):S43–S45. 10.1097/00008469-199703001-00009
40. Rowland I, Gibson G, Heinken A, Scott K, Swann J, Thiele I, Tuohy K (2018) Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr 57:1–24. 10.1007/s00394-017-1445-8
41. Magnúsdóttir S, Ravcheev D, de Crécy-Lagard V, Thiele I (2015) Systematic genome assessment of B-vitamin biosynthesis suggests co-operation among gut microbes. Front Genet 6:148. 10.3389/fgene.2015.00148
42. Said HM, Ortiz A, Moyer MP, Yanagawa N (2000) Riboflavin uptake by human-derived colonic epithelial NCM460 cells. Am J Phys Cell Phys 278:C270–C276. 10.1152/ajpcell.2000.278.2.C270
43. Shin R, Suzuki M, Morishita Y (2002) Influence of intestinal anaerobes and organic acids on the growth of enterohaemorrhagic Escherichia coli O157:H7. J Med Microbiol 51:201–206. 10.1099/0022-1317-51-3-201
44. Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, Calder PC, Sanders ME (2014) Expert consensus document. The international scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol 11:506–514. 10.1038/nrgastro.2014.66